ISG15 and Hepatitis: Overall, we hypothesized that ISGs primarily expressed by hepatocytes during the HBeAg‐positive infection phase and by B cells during HBeAg‐negative infection and hepatitis phases, such as IFI44, ISG15, MX1, and OAS3, showed no correlation with ALT levels.